Close
Nordic 9Nordic 9

Thioredoxin Systems (private company)

Sweden txnsystems.com
See something wrong or missing? Let us know
Offices:Stockholm
Industry:BiotechHealth servicesPharma
Business model:B2B

Thioredoxin Systems is a pharma startup in Sweden developing an antibiotic regimen for complicated urinary tract infections.

Investors: we tracked 6 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 2.4M

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Thioredoxin Systems

Name Criteria
France PEP-Therapy
73%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 2
  • At least one vc investor: found 1
  • At least one other investor: found 2
  • Total raised in a similar range: 1M - 5M USD
Sweden Atley Solutions
73%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 3
  • At least one vc investor: found 1
  • At least one other investor: found 2
  • Total raised in a similar range: 1M - 5M USD
United Kingdom Mable
73%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 1
  • At least one other investor: found 2
  • Total raised in a similar range: 1M - 5M USD
Sweden Pila Pharma
70%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
France Vaxxel
70%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 2
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
United Kingdom BDD
70%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one other investor: found 2
  • Total raised in a similar range: 1M - 5M USD
Ireland Ovagen
70%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 3
  • At least one other investor: found 2
  • Total raised in a similar range: 1M - 5M USD
Sweden Cinclus Pharma
68%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 3
  • At least one vc investor: found 1
  • At least one other investor: found 2
Denmark Octarine Bio
68%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 1
  • At least one other investor: found 2
United Kingdom Causaly
68%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 3
  • At least one vc investor: found 1
  • At least one other investor: found 2
Top